Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Intact Vascular, founded in 2011 and headquartered in Wayne, Pennsylvania, is a medical device company specializing in minimally invasive peripheral vascular products. The company has made significant strides in the healthcare industry, raising a total of $160 million in funding since its inception. Intact Vascular's innovative approach to vascular treatments has positioned it as a notable player in the medical device sector.
On August 27, 2020, Intact Vascular was acquired by Philips, a global leader in health technology. This acquisition marked a significant milestone for the company, potentially impacting its future trajectory and market position. Given this development, the prospect of an initial public offering (IPO) for Intact Vascular is currently uncertain.
As of now, we have not found any concrete information or reports regarding Intact Vascular's IPO plans. The company's acquisition by Philips may have altered any previous considerations for going public. It's important to note that decisions about IPOs are complex and can be influenced by various factors, including market conditions, company performance, and strategic goals.
Investors interested in the medical device industry and companies like Intact Vascular should continue to monitor official announcements and financial news for the most up-to-date and accurate information. As always, it's crucial to conduct thorough research and consider multiple sources when evaluating potential investment opportunities in the healthcare sector.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Intact Vascular's IPO prospects remain uncertain, investors interested in the medical device and vascular health sector don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry leaders like Intact Vascular, with lower minimum investments than traditional private equity opportunities. This allows you to diversify your portfolio and potentially benefit from the growth of innovative medical technology companies before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
